Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. opioid addiction
Show results for
Products
Applications

Companies

News
Articles

Refine by
Date

  • Older

Opioid Addiction Articles & Analysis

14 news found

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent

Bexson’s lead therapy, BB106, is a low-dose ketamine treatment for post-operative pain management, a $36B global market and leading driver of opioid addiction. Additionally, management believes its BB106 formulation technology can be utilized to address various mental health ...

ByBexson Biomedical


Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Bexson’s lead therapy, BB106, is a low-dose ketamine treatment for post-operative pain management, a$36B global market and leading driver of opioid addiction. Additionally, management believes its BB106formulation technology can be utilized to address various mental health ...

ByBexson Biomedical


gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder

gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder

Substance use is an escalating crisis in the United States, with opioid-related drug overdose deaths rising above 100,000 in 2021.1 The standard of care for treating opioid use disorder (OUD) is medication for opioid use disorder (MOUD), including opioid receptor agonists and antagonists. ...

ByelectroCore, Inc.


Berkshire Biomedical, Developers of COPA, Recognizes National Prescription Drug Take Back Day

Berkshire Biomedical, Developers of COPA, Recognizes National Prescription Drug Take Back Day

DEA’s National Prescription Drug Take Back Day reflects DEA’s commitment to Americans’ safety and health, encouraging the public to remove unneeded medications from their homes as a measure of preventing medication misuse and opioid addiction from ever starting. The Berkshire team supports the DEA’s commitment to making communities safer ...

ByBerkshire Biomedical


Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device

Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device

According to recent market research pain following surgery is a $35.5 billion market and is a leading cause of opioid abuse and addiction. The Company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds. ...

ByBexson Biomedical


Berkshire Biomedical, Developers of COPA,  Featured as a 2022 Top Texas Tech Startup in StartupCity Magazine

Berkshire Biomedical, Developers of COPA, Featured as a 2022 Top Texas Tech Startup in StartupCity Magazine

The initial intended use for COPA will include the delivery of opioids for the treatment of chronic pain and the delivery of methadone in Medication Assisted Therapy for the treatment of opioid use disorder. ...

ByBerkshire Biomedical


Berkshire Biomedical to Present at the LSI USA ’22 Emerging Medtech Summit

Berkshire Biomedical to Present at the LSI USA ’22 Emerging Medtech Summit

The Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of controlled oral liquid medications for chronic pain and opioid addiction medication assisted therapy, as the Company believes they have the greatest need for the benefits of COPA’s features. ...

ByBerkshire Biomedical


Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Three overarching features combine to make the COPA technology unique: security, compliance support (metrics) with remote monitoring and precise liquid dispensing. Chronic pain and opioid addiction medication assisted therapy have been identified as potential indications with the greatest need for the benefits of these features. ...

ByBerkshire Biomedical


Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

Of significant collateral importance is the current epidemic of opioid addiction and abuse by patients in the United States and around the globe. In 2015, abuse liability statistics for opioid misusers who obtained opioids from the prescribed patient was as high as 54%. ...

ByNeuropathix, Inc.


Berkshire Biomedical Recognizes International Overdose Awareness Day

Berkshire Biomedical Recognizes International Overdose Awareness Day

The goal of International Overdose Awareness Day is to raise awareness, elevate the public understanding of the global addiction burden, promote greater understanding of the tragedy of drug overdose death and, importantly, to advance evidence-based overdose prevention and drug policy. “We applaud those dedicated to raising awareness of the global overdose and ...

ByBerkshire Biomedical


Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Bexson Biomedical, Inc., a research-stage company developing therapies and delivery solutions for pain management, addiction and mental health indications, announced today that the U.S. ...

ByBexson Biomedical


Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances

Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances

With his help, the technology we're developing with Stevanato Group has great potential for application beyond our non-opioid BB106 therapy for pain management," said Jeffrey Becker, co-founder and CSO, Bexson Biomedical. ...

ByBexson Biomedical


Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A

Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A

Bexson Biomedical, Inc., a research-stage company developing a subcutaneous ketamine treatment platform for pain management and mental health disorders, announced today that they closed a $4.8 million Series A round of financing. Funding will support the company through pre-clinical and GMP manufacturing scale up for its proprietary ketamine formulation, BB106, and the development of a wearable ...

ByBexson Biomedical


The Drug Enforcement Administration, DEA Educational Foundation, and Discovery Education Announce Winners for 2019 ‘Operation Prevention’ Video Challenge

The Drug Enforcement Administration, DEA Educational Foundation, and Discovery Education Announce Winners for 2019 ‘Operation Prevention’ Video Challenge

The challenge invited teens across the nation to submit 30-60 second video public service announcements that capture their unique voice in order to communicate the opioid epidemic as a national crisis. In What Could’ve Been, a teenager’s opioid addiction shortens his life, halting the joys of growing into his adulthood. The character ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT